Fresenius Medical Care AG & Co. KGaA (ADR) (NYSE:FMS)

CAPS Rating: 5 out of 5

The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.

Recs

1
Player Avatar ThatGuy73 (96.07) Submitted: 5/1/2008 3:46:29 PM : Outperform Start Price: $50.06 FMS Score: +36.16

I've never been good at picks in the medical sector. I like this company for its investment in Renal Solutions, since I can't buy into Renal solutions directly. Here's a blurb about Renal Solutions:

The nature of our new approach -- using living cells as therapeutic agents -- argues for the feasibility of developing whole classes of new cell-based and tissue engineered therapies. The ability to harness vital processes of cells, to target their living molecular machinery on restoring critical substances which have become disordered by disease, has vast implications for the future of medicine. The apparently successful use of living cells in this way validates our approach and should encourage others to investigate cell therapies for a range of disorders.

Featured Broker Partners


Advertisement